Dexmedetomidine in the Treatment of Symptoms Of Acute Opioid Withdrawal
Clinical trial NCT04470050 · COMPLETED
Trial details
- NCT number
- NCT04470050
- Sponsor
- BioXcel Therapeutics Inc
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-09
- Primary completion
- 2021-02-18
- Enrollment
- 225
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.